Who it affects
- People enrolled in Medicare Advantage, Medicaid, or CHIP
- People covered by TRICARE
- People receiving Department of Veterans Affairs health benefits
- People receiving Indian Health Service care
H.R. 9946 · House bill · Introduced July 23, 2026
The Equity in STI Testing Act would cover testing for certain sexually transmitted infections without patient costs for people in specified federal health programs.
In committee
No recorded votes yet.
See each vote ↓No lobbying reported yet
Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.
Written with AI from the official summary by Congress's research office.
No recorded roll-call vote on this bill yet.
PAC, lobbyist campaign and qualifying employee money this election, shown separately and never added together. Lobbying reports name the bills a group worked on, not which side it took.
No lobbying reported yet. Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.
Equity in STI Testing Act This bill provides for coverage, without cost-sharing, of testing for certain sexually transmitted infections under Medicare Advantage, Medicaid, the Children's Health Insurance Program (CHIP), TRICARE, Department of Veterans Affairs health benefits, and the Indian Health Service.
Summary on Congress.gov ↗No lobbying report we have loaded names this bill. That doesn't mean no lobbying took place.
Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published. Reports for October through December 2026 are due January 20, 2027.